I missed some of your questions. Our product showed little help...

I missed some of your questions.

Our product showed little help for the Margolis 2 categorised ulcers. Vitrogrow (or whatever it's called today) is a substance that helps the patient heal themselves. It is the patient that's doing the healing, we just help.

The Margolis 2 categorised ulcer patents are generally of very poor health, and they are not responding much despite our help.

One other important thing to consider is that these ulcers are quite painful. ftt's product has reduced this pain considerably in the past trial. This is being documented in our trial and can make our product more commercial and more likely to be approved.

cheers